doi: 10.1039/c6ob00099a.
Phthalocyanine-cRGD conjugate: synthesis, photophysical properties and in vitro biological activity for targeting photodynamic therapy
Affiliations
- PMID: 26883209
- DOI: 10.1039/c6ob00099a
Item in Clipboard
Phthalocyanine-cRGD conjugate: synthesis, photophysical properties and in vitro biological activity for targeting photodynamic therapy
Org Biomol Chem.
.
Abstract
An unsymmetrical phthalocyanine conjugated with an RGDyK moiety (6) was synthesized and characterized. Its photophysical properties, including electronic absorption, fluorescence emission (ΦF = 0.20), singlet oxygen quantum yield (ΦΔ = 0.63) and two-photon absorption cross section (TPACS) at different wavelengths were studied. The in vitro cell study data demonstrate that this Pc conjugate possesses significantly high cellular uptake toward the ανβ3 positive DU145 prostate cancer cells along with an efficient photocytotoxicity (IC50 = 0.04 μM), showing this compound is one of the most promising photosensitizers for targeting photodynamic therapy (PDT) of cancer.
Similar articles
-
Synthesis and in vitro photodynamic activities of an integrin-targeting cRGD-conjugated zinc(II) phthalocyanine.Chem Asian J. 2014 Feb;9(2):554-61. doi: 10.1002/asia.201301166. Epub 2013 Nov 7. Chem Asian J. 2014. PMID: 24203795
-
Spectroscopic insights on imidazole substituted phthalocyanine photosensitizers: fluorescence properties, triplet state and singlet oxygen generation.Spectrochim Acta A Mol Biomol Spectrosc. 2014 Dec 10;133:752-8. doi: 10.1016/j.saa.2014.06.063. Epub 2014 Jun 19. Spectrochim Acta A Mol Biomol Spectrosc. 2014. PMID: 24997445
-
Glycosylated zinc(II) phthalocyanines as efficient photosensitisers for photodynamic therapy. Synthesis, photophysical properties and in vitro photodynamic activity.Org Biomol Chem. 2008 Jun 21;6(12):2173-81. doi: 10.1039/b802212g. Epub 2008 Apr 18. Org Biomol Chem. 2008. PMID: 18528579
-
Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy.J Pharm Biomed Anal. 2014 Jan;87:98-104. doi: 10.1016/j.jpba.2013.05.014. Epub 2013 May 18. J Pharm Biomed Anal. 2014. PMID: 23746989 Review.
-
Prospects for More Efficient Multi-Photon Absorption Photosensitizers Exhibiting Both Reactive Oxygen Species Generation and Luminescence.Molecules. 2021 Oct 19;26(20):6323. doi: 10.3390/molecules26206323. Molecules. 2021. PMID: 34684904 Free PMC article. Review.
Cited by
-
Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities.Front Oncol. 2022 Sep 23;12:980239. doi: 10.3389/fonc.2022.980239. eCollection 2022. Front Oncol. 2022. PMID: 36212416 Free PMC article. Review.
-
Effect of tertiary amino groups in the hydrophobic segment of an amphiphilic block copolymer on zinc phthalocyanine encapsulation and photodynamic activity.RSC Adv. 2022 Jun 21;12(28):18144-18153. doi: 10.1039/d2ra02224a. eCollection 2022 Jun 14. RSC Adv. 2022. PMID: 35800304 Free PMC article.
-
Nanoparticles Yield Increased Drug Uptake and Therapeutic Efficacy upon Sequential Near-Infrared Irradiation.ACS Nano. 2020 Nov 24;14(11):15193-15203. doi: 10.1021/acsnano.0c05425. Epub 2020 Oct 22. ACS Nano. 2020. PMID: 33090762 Free PMC article.
-
Light-Induced Therapies for Prostate Cancer Treatment.Front Chem. 2019 Oct 29;7:719. doi: 10.3389/fchem.2019.00719. eCollection 2019. Front Chem. 2019. PMID: 31737599 Free PMC article. Review.
-
Multimerization Increases Tumor Enrichment of Peptide⁻Photosensitizer Conjugates.Molecules. 2019 Feb 25;24(4):817. doi: 10.3390/molecules24040817. Molecules. 2019. PMID: 30823562 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
